Sample Request

COVID-19 Outbreak-Global Extra Corporeal Membrane Oxygenation (ECMO) System Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

SELECT LICENSE:

Published on 01/14/2021| Code: MAR41115D| Category: Utilities| Total Pages: 112

The Extra Corporeal Membrane Oxygenation (ECMO) System market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Extra Corporeal Membrane Oxygenation (ECMO) System industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Extra Corporeal Membrane Oxygenation (ECMO) System market can be split based on product types, major applications, and important countries as follows:

Key players in the global Extra Corporeal Membrane Oxygenation (ECMO) System market covered in Chapter 12:

Xenios AG (FRESENIUS SE & CO. KGAA)​​
Eurosets
Medtronic PLC
Alung Technologies Inc.
Microport Scientific Corporation
Abbott Laboratories
Getinge AB
Terumo Medical Corporation
Nipro Medical Corporation
Livanova Plc

In Chapter 4 and 14.1, on the basis of types, the Extra Corporeal Membrane Oxygenation (ECMO) System market from 2015 to 2025 is primarily split into:

VA (Veno-Arterial) ECMO
VV (Veno-Venous) ECMO

In Chapter 5 and 14.2, on the basis of applications, the Extra Corporeal Membrane Oxygenation (ECMO) System market from 2015 to 2025 covers:

Neonatal
Pediatric
Adult

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Extra Corporeal Membrane Oxygenation (ECMO) System Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Extra Corporeal Membrane Oxygenation (ECMO) System

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Extra Corporeal Membrane Oxygenation (ECMO) System industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Size, 2015 – 2020

2.1.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Type, 2015 – 2020

2.1.3 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Application, 2015 – 2020

2.1.4 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Region, 2015 - 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on Extra Corporeal Membrane Oxygenation (ECMO) System Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of Extra Corporeal Membrane Oxygenation (ECMO) System Analysis

3.2 Major Players of Extra Corporeal Membrane Oxygenation (ECMO) System

3.3 Extra Corporeal Membrane Oxygenation (ECMO) System Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of Extra Corporeal Membrane Oxygenation (ECMO) System

3.3.3 Labor Cost of Extra Corporeal Membrane Oxygenation (ECMO) System

3.4 Market Distributors of Extra Corporeal Membrane Oxygenation (ECMO) System

3.5 Major Downstream Buyers of Extra Corporeal Membrane Oxygenation (ECMO) System Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market, by Type

4.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Value and Market Share by Type (2015-2020)

4.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Production and Market Share by Type (2015-2020)

4.3 Global Extra Corporeal Membrane Oxygenation (ECMO) System Value and Growth Rate by Type (2015-2020)

4.3.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Value and Growth Rate of VA (Veno-Arterial) ECMO
4.3.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Value and Growth Rate of VV (Veno-Venous) ECMO
4.4 Global Extra Corporeal Membrane Oxygenation (ECMO) System Price Analysis by Type (2015-2020)

5 Extra Corporeal Membrane Oxygenation (ECMO) System Market, by Application

5.1 Downstream Market Overview

5.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Consumption and Market Share by Application (2015-2020)

5.3 Global Extra Corporeal Membrane Oxygenation (ECMO) System Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Consumption and Growth Rate of Neonatal (2015-2020)
5.3.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Consumption and Growth Rate of Pediatric (2015-2020)
5.3.3 Global Extra Corporeal Membrane Oxygenation (ECMO) System Consumption and Growth Rate of Adult (2015-2020)

6 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Analysis by Regions

6.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Sales, Revenue and Market Share by Regions

6.1.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Sales by Regions (2015-2020)

6.1.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Revenue by Regions (2015-2020)

6.2 North America Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

6.3 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

6.6 South America Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

7 North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America Extra Corporeal Membrane Oxygenation (ECMO) System Sales, Revenue and Market Share by Countries

7.2.1 North America Extra Corporeal Membrane Oxygenation (ECMO) System Sales by Countries (2015-2020)

7.2.2 North America Extra Corporeal Membrane Oxygenation (ECMO) System Revenue by Countries (2015-2020)

7.3 United States Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

7.4 Canada Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

7.5 Mexico Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

8 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Sales, Revenue and Market Share by Countries

8.2.1 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Sales by Countries (2015-2020)

8.2.2 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Revenue by Countries (2015-2020)

8.3 Germany Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

8.4 UK Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

8.5 France Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

8.6 Italy Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

8.7 Spain Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

8.8 Russia Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

9 Asia Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Sales by Countries (2015-2020)

9.2.2 Asia Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Revenue by Countries (2015-2020)

9.3 China Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

9.4 Japan Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

9.5 South Korea Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

9.6 India Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

9.7 Southeast Asia Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

9.8 Australia Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

10 Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Sales by Countries (2015-2020)

10.2.2 Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Revenue by Countries (2015-2020)

10.3 Saudi Arabia Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

10.4 UAE Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

10.5 Egypt Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

10.6 Nigeria Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

10.7 South Africa Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

11 South America Extra Corporeal Membrane Oxygenation (ECMO) System Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America Extra Corporeal Membrane Oxygenation (ECMO) System Sales, Revenue and Market Share by Countries

11.2.1 South America Extra Corporeal Membrane Oxygenation (ECMO) System Sales by Countries (2015-2020)

11.2.2 South America Extra Corporeal Membrane Oxygenation (ECMO) System Revenue by Countries (2015-2020)

11.3 Brazil Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

11.4 Argentina Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

11.5 Columbia Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

11.6 Chile Extra Corporeal Membrane Oxygenation (ECMO) System Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 Xenios AG (FRESENIUS SE & CO. KGAA)​​
12.1.1 Xenios AG (FRESENIUS SE & CO. KGAA)​​ Basic Information
12.1.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.1.3 Xenios AG (FRESENIUS SE & CO. KGAA)​​ Production, Value, Price, Gross Margin 2015-2020
12.2 Eurosets
12.2.1 Eurosets Basic Information
12.2.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.2.3 Eurosets Production, Value, Price, Gross Margin 2015-2020
12.3 Medtronic PLC
12.3.1 Medtronic PLC Basic Information
12.3.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.3.3 Medtronic PLC Production, Value, Price, Gross Margin 2015-2020
12.4 Alung Technologies Inc.
12.4.1 Alung Technologies Inc. Basic Information
12.4.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.4.3 Alung Technologies Inc. Production, Value, Price, Gross Margin 2015-2020
12.5 Microport Scientific Corporation
12.5.1 Microport Scientific Corporation Basic Information
12.5.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.5.3 Microport Scientific Corporation Production, Value, Price, Gross Margin 2015-2020
12.6 Abbott Laboratories
12.6.1 Abbott Laboratories Basic Information
12.6.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.6.3 Abbott Laboratories Production, Value, Price, Gross Margin 2015-2020
12.7 Getinge AB
12.7.1 Getinge AB Basic Information
12.7.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.7.3 Getinge AB Production, Value, Price, Gross Margin 2015-2020
12.8 Terumo Medical Corporation
12.8.1 Terumo Medical Corporation Basic Information
12.8.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.8.3 Terumo Medical Corporation Production, Value, Price, Gross Margin 2015-2020
12.9 Nipro Medical Corporation
12.9.1 Nipro Medical Corporation Basic Information
12.9.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.9.3 Nipro Medical Corporation Production, Value, Price, Gross Margin 2015-2020
12.10 Livanova Plc
12.10.1 Livanova Plc Basic Information
12.10.2 Extra Corporeal Membrane Oxygenation (ECMO) System Product Introduction
12.10.3 Livanova Plc Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Forecast

14.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 VA (Veno-Arterial) ECMO Market Value and Volume Forecast (2020-2025)
14.1.2 VV (Veno-Venous) ECMO Market Value and Volume Forecast (2020-2025)
14.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 Neonatal Market Value and Volume Forecast (2020-2025)
14.2.2 Pediatric Market Value and Volume Forecast (2020-2025)
14.2.3 Adult Market Value and Volume Forecast (2020-2025)
14.3 Extra Corporeal Membrane Oxygenation (ECMO) System Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Mizuno corporation
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005